Physician profile
Michael Coyle
NPI 1083848436
$343.44
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.97 · 2021: $45.52 · 2022: $111 · 2023: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $119 · Food and Beverage: $43.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $119.00 |
| Food and Beverage | $43.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $98.00 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $59.50 | 2021-2023 | |
| Genentech USA, INC. | $35.10 | 2022 | |
| Eisai INC. | $26.56 | 2023 | |
| Blueprint Medicines Corporation | $24.33 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $23.97 | 2020 | |
| Epizyme, INC. | $21.46 | 2021 | |
| Celgene Corporation | $21.10 | 2022 | |
| Mirati Therapeutics, INC. | $21.00 | 2023 | Krazati |
| Incyte Corporation | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.